Ophthalmic Disease Therapeutics Market to Reach USD 74.7 Billion by 2032 at 8.9% CAGR
The global Ophthalmic Disease Therapeutics Market is witnessing strong growth as the prevalence of vision-related disorders continues to rise alongside an aging global population. Increasing incidences of cataracts, glaucoma, age-related macular degeneration (AMD), diabetic retinopathy, and dry eye disease are driving demand for advanced therapeutic solutions. According to Stellar Market Research, the Ophthalmic Disease Therapeutics Market … Read more